等待開盤 07-06 09:30:00 美东时间
+0.680
+1.12%
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst takes on their favorite stocks by v...
06-25 19:36
Cheniere Energy Partners已与柏克德能源公司就路易斯安那州萨宾帕斯LNG扩建项目一期工程签署了总价交钥匙工程、采购和建设(EPC)合同...
05-29 21:00
Cheniere signs deal with Bechtel to expand US LNG export capacity May 28 (Reuters) - Cheniere Energy Partners CQP.N said on Thursday it had signed a contract with Bechtel Energy for engineering, procurement and construction for the first phase of its Sabine Pass LNG expansion project in Cameron Pari
05-28 21:19
Cheniere Energy Partners (CQP) said on Tuesday it priced a $1B offering of senior notes due 2036 and a $750M offering of senior notes due 2056. The 2036 notes will carry an interest rate of 5.35%, whi...
05-27 05:37
Cheniere Energy Partners (CQP), a subsidiary of Cheniere Energy (LNG), announced on Tuesday that it plans to raise funds via offering new Senior Notes due 2036 and 2056, subject to market conditions. ...
05-26 21:41
Cheniere Energy Partners plans senior notes offering due 2036 and 2056 Cheniere Energy Partners launched an offering of Senior Notes due 2036, alongside Senior Notes due 2056. Proceeds earmarked for general partnership purposes, including refinancing or redemption of existing debt, capital spending,
05-26 20:40
Cheniere Energy Partners (AMEX:CQP) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $1.15 by 83.48 percent. This is a 82.41 percent decrease over earnings of $1.08 per share
05-07 19:10
最高股息率超12%!塔吉特、南方电力、福特汽车等超80家公司即将分红!投资者若想赚取股息,可趁未除净适时部署,一文速览派息名单>>
05-04 19:17
Cheniere Energy Partners (CQP) declares $0.79/share quarterly dividend. Forward yield 5.04% Payable May 15; for shareholders of record May 8; ex-div May 8. The cash distribution comprised a base amoun...
04-28 21:09
今日重点评级关注:Leerink Partners:维持Camp4 Therapeutics"跑赢大市"评级,目标价从8美元升至9美元;韦德布什:维持Arcus Biosciences"跑赢大市"评级,目标价从37美元升至41美元
04-06 16:27